Validating Regulator Support for Your Compliance Approach Before You Build

Start with the assumption you are wrong

Most product launches in regulated markets fail validation not because the compliance design is poor, but because the team assumed regulator support based on indirect signals: a speech, a consultation response, a friendly conversation at an industry dinner. None of these tell you whether the specific regulator who will assess your product, applying their specific current priorities, will back your specific approach.

Before you spend another pound on build, write down the three or four core compliance judgements your product depends on. Not the regulation itself, the judgement calls you have made interpreting it. These are what you need to test.

Map the decision-makers who actually matter

There is a difference between the regulator as an institution and the people who will form a view on your product. Identify the supervisor or policy lead whose desk this will land on, their manager, and the technical specialists they will consult. Add the industry bodies whose positions will be cited back at you, and the two or three peer firms whose silence or objection will carry weight.

What most teams get wrong: they focus on the most senior name they can get to and treat that conversation as definitive. The senior name rarely writes the assessment. The person two levels down does, and they have their own view shaped by recent cases you may not know about.

Sequence the conversations carefully

Order matters more than people think. Start with the stakeholders who will give you the most candid read with the lowest political cost: former regulators now in advisory roles, trade body technical staff, and counsel who have run similar approvals recently. Use these conversations to sharpen your questions and identify the specific objections you need to test.

Only then approach current regulators, and approach them with a structured proposition, not an open question. "We are considering an approach where X, Y and Z. We have assumed A, B and C. Where would you push back?" gets you a useful answer. "We wanted to understand your thinking on this space" gets you a recitation of published policy.

Read what you are actually being told

Regulators rarely say no directly at this stage. They signal through the questions they ask, the comparisons they draw, and what they do not say. If a supervisor spends twenty minutes on your governance arrangements and two minutes on the product mechanics, the governance is where the concern sits. If they ask whether you have spoken to a specific other team, that team has a view you need to find.

The most dangerous signal is polite encouragement with no specifics. It usually means the person you are speaking to is not the person who will decide, and they are being careful not to commit anyone who will.

Test the industry view independently

Decision-makers do not form views in isolation. They check with peers, read submissions from competitors, and weigh how the market will react. Run a parallel track to test how three or four major industry players will respond. You are not asking permission, you are testing whether they will actively object, quietly tolerate, or publicly support. Each of those produces a very different regulatory dynamic.

If two significant competitors will object on substantive grounds, your compliance approach has a problem regardless of what the regulator privately tells you.

Decide what would change your mind

Before the conversations start, write down what you would need to hear to stop, to modify materially, or to proceed as planned. Without this, confirmation bias takes over. Teams that have already presented a business case to the board will hear support in ambiguous responses.

Good looks like: a one page summary after the validation work that states, in plain terms, which of your core compliance judgements have been tested, by whom, with what response, and where residual uncertainty sits. If you cannot write that page, you have not validated anything.

The decision point

Before your next investment committee, answer one question: can you name the specific individuals at the regulator and across the industry who have seen your actual compliance approach and indicated where they would push back? If the answer is no, the validation work has not started, regardless of how many meetings have happened.